 | • レポートコード：QFJ1-4078 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、皮角治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドラッグ、レーザーデバイス）、用途別市場規模（小売薬局、ドラッグストア、Eコマース、病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・皮角治療の市場動向 ・企業の競争状況、市場シェア ・皮角治療の種類別市場規模と予測2016-2027（ドラッグ、レーザーデバイス） ・皮角治療の用途別市場規模と予測2016-2027（小売薬局、ドラッグストア、Eコマース、病院、専門クリニック、その他） ・皮角治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮角治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮角治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮角治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮角治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche AG、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Meda Ab、Sun Pharmaceutical Industries Ltd.、GlaxoSmithKline plc.、Vidac Pharma、Bausch Health Companies Inc.、ImClone Systems Incorporated、Sanofi SA、Ushio, Inc.、Hetero Pharmaceuticals、Merck & Co., Inc.、Cipla Limited） ・結論 |
Cutaneous horn (Cornu cutaneum) is an adequately undynamic projectile, asymmetrical, hyperkeratosis bump. It is a typical type of non-melanoma skin cancer. Although 60% of the cutaneous horns are not harmful in nature, the probability of skin cancer is going to occur. Excisional biopsy is adequate for treatment of the lesion which is present overhead and face. But if cornu cutaneum is enclosed of sensitive cosmetic areas then Electro cauterization, laser ablation, and cryotherapy are new develop technologies establish in the cornu cutaneum treatment market. According to the annual report American cancer society, it is estimated that in 2020, 100,350 new cases, of skin cancer will be diagnosed in the US and 6,850 people will die in the US. While from 100,350 there are 60,190 are male and 40,160 female will be diagnosed by cornu cutaneum treatment. Also According to the American cancer society, the overall incidence of melanoma skin cancer rise rapidly over the past 30 years, but trends in the past decade vary by age. Started from 2007 till 2016, the percentage decreased by 1.2% per year in individuals younger than 50 years of age while increasing by 2.2% per year amongst ages 50 and older.
Market Analysis and Insights: Global Cutaneous Horn Treatment Market
The global Cutaneous Horn Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cutaneous Horn Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cutaneous Horn Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cutaneous Horn Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cutaneous Horn Treatment market.
Global Cutaneous Horn Treatment Scope and Market Size
Cutaneous Horn Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Horn Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drugs
Laser Devices
Segment by Application
Retail Pharmacy
Drugstore
E-Commerce
Hospitals
Specialty Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Meda Ab
Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc.
Vidac Pharma
Bausch Health Companies Inc.
ImClone Systems Incorporated
Sanofi SA
Ushio, Inc.
Hetero Pharmaceuticals
Merck & Co., Inc.
Cipla Limited
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Horn Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Laser Devices
1.3 Market by Application
1.3.1 Global Cutaneous Horn Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacy
1.3.3 Drugstore
1.3.4 E-Commerce
1.3.5 Hospitals
1.3.6 Specialty Clinics
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Horn Treatment Market Perspective (2016-2027)
2.2 Cutaneous Horn Treatment Growth Trends by Regions
2.2.1 Cutaneous Horn Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cutaneous Horn Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cutaneous Horn Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cutaneous Horn Treatment Industry Dynamic
2.3.1 Cutaneous Horn Treatment Market Trends
2.3.2 Cutaneous Horn Treatment Market Drivers
2.3.3 Cutaneous Horn Treatment Market Challenges
2.3.4 Cutaneous Horn Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Horn Treatment Players by Revenue
3.1.1 Global Top Cutaneous Horn Treatment Players by Revenue (2016-2021)
3.1.2 Global Cutaneous Horn Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cutaneous Horn Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Horn Treatment Revenue
3.4 Global Cutaneous Horn Treatment Market Concentration Ratio
3.4.1 Global Cutaneous Horn Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Horn Treatment Revenue in 2020
3.5 Cutaneous Horn Treatment Key Players Head office and Area Served
3.6 Key Players Cutaneous Horn Treatment Product Solution and Service
3.7 Date of Enter into Cutaneous Horn Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cutaneous Horn Treatment Breakdown Data by Type
4.1 Global Cutaneous Horn Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cutaneous Horn Treatment Forecasted Market Size by Type (2022-2027)
5 Cutaneous Horn Treatment Breakdown Data by Application
5.1 Global Cutaneous Horn Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cutaneous Horn Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cutaneous Horn Treatment Market Size (2016-2027)
6.2 North America Cutaneous Horn Treatment Market Size by Type
6.2.1 North America Cutaneous Horn Treatment Market Size by Type (2016-2021)
6.2.2 North America Cutaneous Horn Treatment Market Size by Type (2022-2027)
6.2.3 North America Cutaneous Horn Treatment Market Size by Type (2016-2027)
6.3 North America Cutaneous Horn Treatment Market Size by Application
6.3.1 North America Cutaneous Horn Treatment Market Size by Application (2016-2021)
6.3.2 North America Cutaneous Horn Treatment Market Size by Application (2022-2027)
6.3.3 North America Cutaneous Horn Treatment Market Size by Application (2016-2027)
6.4 North America Cutaneous Horn Treatment Market Size by Country
6.4.1 North America Cutaneous Horn Treatment Market Size by Country (2016-2021)
6.4.2 North America Cutaneous Horn Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cutaneous Horn Treatment Market Size (2016-2027)
7.2 Europe Cutaneous Horn Treatment Market Size by Type
7.2.1 Europe Cutaneous Horn Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cutaneous Horn Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cutaneous Horn Treatment Market Size by Type (2016-2027)
7.3 Europe Cutaneous Horn Treatment Market Size by Application
7.3.1 Europe Cutaneous Horn Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cutaneous Horn Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cutaneous Horn Treatment Market Size by Application (2016-2027)
7.4 Europe Cutaneous Horn Treatment Market Size by Country
7.4.1 Europe Cutaneous Horn Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cutaneous Horn Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Horn Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cutaneous Horn Treatment Market Size by Type
8.2.1 Asia-Pacific Cutaneous Horn Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cutaneous Horn Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cutaneous Horn Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cutaneous Horn Treatment Market Size by Application
8.3.1 Asia-Pacific Cutaneous Horn Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cutaneous Horn Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cutaneous Horn Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cutaneous Horn Treatment Market Size by Region
8.4.1 Asia-Pacific Cutaneous Horn Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cutaneous Horn Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cutaneous Horn Treatment Market Size (2016-2027)
9.2 Latin America Cutaneous Horn Treatment Market Size by Type
9.2.1 Latin America Cutaneous Horn Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cutaneous Horn Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cutaneous Horn Treatment Market Size by Type (2016-2027)
9.3 Latin America Cutaneous Horn Treatment Market Size by Application
9.3.1 Latin America Cutaneous Horn Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cutaneous Horn Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cutaneous Horn Treatment Market Size by Application (2016-2027)
9.4 Latin America Cutaneous Horn Treatment Market Size by Country
9.4.1 Latin America Cutaneous Horn Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cutaneous Horn Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Horn Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cutaneous Horn Treatment Market Size by Type
10.2.1 Middle East & Africa Cutaneous Horn Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cutaneous Horn Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cutaneous Horn Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cutaneous Horn Treatment Market Size by Application
10.3.1 Middle East & Africa Cutaneous Horn Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cutaneous Horn Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cutaneous Horn Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cutaneous Horn Treatment Market Size by Country
10.4.1 Middle East & Africa Cutaneous Horn Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cutaneous Horn Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Cutaneous Horn Treatment Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche AG Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Cutaneous Horn Treatment Introduction
11.2.4 Pfizer Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.2.5 Pfizer Inc. Recent Development
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Company Details
11.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Cutaneous Horn Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.4 Meda Ab
11.4.1 Meda Ab Company Details
11.4.2 Meda Ab Business Overview
11.4.3 Meda Ab Cutaneous Horn Treatment Introduction
11.4.4 Meda Ab Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.4.5 Meda Ab Recent Development
11.5 Sun Pharmaceutical Industries Ltd.
11.5.1 Sun Pharmaceutical Industries Ltd. Company Details
11.5.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.5.3 Sun Pharmaceutical Industries Ltd. Cutaneous Horn Treatment Introduction
11.5.4 Sun Pharmaceutical Industries Ltd. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.5.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.6 GlaxoSmithKline plc.
11.6.1 GlaxoSmithKline plc. Company Details
11.6.2 GlaxoSmithKline plc. Business Overview
11.6.3 GlaxoSmithKline plc. Cutaneous Horn Treatment Introduction
11.6.4 GlaxoSmithKline plc. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline plc. Recent Development
11.7 Vidac Pharma
11.7.1 Vidac Pharma Company Details
11.7.2 Vidac Pharma Business Overview
11.7.3 Vidac Pharma Cutaneous Horn Treatment Introduction
11.7.4 Vidac Pharma Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.7.5 Vidac Pharma Recent Development
11.8 Bausch Health Companies Inc.
11.8.1 Bausch Health Companies Inc. Company Details
11.8.2 Bausch Health Companies Inc. Business Overview
11.8.3 Bausch Health Companies Inc. Cutaneous Horn Treatment Introduction
11.8.4 Bausch Health Companies Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.8.5 Bausch Health Companies Inc. Recent Development
11.9 ImClone Systems Incorporated
11.9.1 ImClone Systems Incorporated Company Details
11.9.2 ImClone Systems Incorporated Business Overview
11.9.3 ImClone Systems Incorporated Cutaneous Horn Treatment Introduction
11.9.4 ImClone Systems Incorporated Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.9.5 ImClone Systems Incorporated Recent Development
11.10 Sanofi SA
11.10.1 Sanofi SA Company Details
11.10.2 Sanofi SA Business Overview
11.10.3 Sanofi SA Cutaneous Horn Treatment Introduction
11.10.4 Sanofi SA Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.10.5 Sanofi SA Recent Development
11.11 Ushio, Inc.
11.11.1 Ushio, Inc. Company Details
11.11.2 Ushio, Inc. Business Overview
11.11.3 Ushio, Inc. Cutaneous Horn Treatment Introduction
11.11.4 Ushio, Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.11.5 Ushio, Inc. Recent Development
11.12 Hetero Pharmaceuticals
11.12.1 Hetero Pharmaceuticals Company Details
11.12.2 Hetero Pharmaceuticals Business Overview
11.12.3 Hetero Pharmaceuticals Cutaneous Horn Treatment Introduction
11.12.4 Hetero Pharmaceuticals Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.12.5 Hetero Pharmaceuticals Recent Development
11.13 Merck & Co., Inc.
11.13.1 Merck & Co., Inc. Company Details
11.13.2 Merck & Co., Inc. Business Overview
11.13.3 Merck & Co., Inc. Cutaneous Horn Treatment Introduction
11.13.4 Merck & Co., Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.13.5 Merck & Co., Inc. Recent Development
11.14 Cipla Limited
11.14.1 Cipla Limited Company Details
11.14.2 Cipla Limited Business Overview
11.14.3 Cipla Limited Cutaneous Horn Treatment Introduction
11.14.4 Cipla Limited Revenue in Cutaneous Horn Treatment Business (2016-2021)
11.14.5 Cipla Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cutaneous Horn Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Laser Devices
Table 4. Global Cutaneous Horn Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cutaneous Horn Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cutaneous Horn Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cutaneous Horn Treatment Market Share by Regions (2016-2021)
Table 8. Global Cutaneous Horn Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cutaneous Horn Treatment Market Share by Regions (2022-2027)
Table 10. Cutaneous Horn Treatment Market Trends
Table 11. Cutaneous Horn Treatment Market Drivers
Table 12. Cutaneous Horn Treatment Market Challenges
Table 13. Cutaneous Horn Treatment Market Restraints
Table 14. Global Cutaneous Horn Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cutaneous Horn Treatment Market Share by Players (2016-2021)
Table 16. Global Top Cutaneous Horn Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Horn Treatment as of 2020)
Table 17. Ranking of Global Top Cutaneous Horn Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cutaneous Horn Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cutaneous Horn Treatment Product Solution and Service
Table 21. Date of Enter into Cutaneous Horn Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cutaneous Horn Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Cutaneous Horn Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cutaneous Horn Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cutaneous Horn Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cutaneous Horn Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Cutaneous Horn Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cutaneous Horn Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cutaneous Horn Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cutaneous Horn Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cutaneous Horn Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cutaneous Horn Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cutaneous Horn Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cutaneous Horn Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cutaneous Horn Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cutaneous Horn Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cutaneous Horn Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cutaneous Horn Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cutaneous Horn Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cutaneous Horn Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cutaneous Horn Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cutaneous Horn Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cutaneous Horn Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cutaneous Horn Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cutaneous Horn Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cutaneous Horn Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cutaneous Horn Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cutaneous Horn Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cutaneous Horn Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cutaneous Horn Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cutaneous Horn Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cutaneous Horn Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cutaneous Horn Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cutaneous Horn Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche AG Company Details
Table 62. F. Hoffmann-La Roche AG Business Overview
Table 63. F. Hoffmann-La Roche AG Cutaneous Horn Treatment Product
Table 64. F. Hoffmann-La Roche AG Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche AG Recent Development
Table 66. Pfizer Inc. Company Details
Table 67. Pfizer Inc. Business Overview
Table 68. Pfizer Inc. Cutaneous Horn Treatment Product
Table 69. Pfizer Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Inc. Recent Development
Table 71. Teva Pharmaceutical Industries Ltd. Company Details
Table 72. Teva Pharmaceutical Industries Ltd. Business Overview
Table 73. Teva Pharmaceutical Industries Ltd. Cutaneous Horn Treatment Product
Table 74. Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 75. Teva Pharmaceutical Industries Ltd. Recent Development
Table 76. Meda Ab Company Details
Table 77. Meda Ab Business Overview
Table 78. Meda Ab Cutaneous Horn Treatment Product
Table 79. Meda Ab Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 80. Meda Ab Recent Development
Table 81. Sun Pharmaceutical Industries Ltd. Company Details
Table 82. Sun Pharmaceutical Industries Ltd. Business Overview
Table 83. Sun Pharmaceutical Industries Ltd. Cutaneous Horn Treatment Product
Table 84. Sun Pharmaceutical Industries Ltd. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 85. Sun Pharmaceutical Industries Ltd. Recent Development
Table 86. GlaxoSmithKline plc. Company Details
Table 87. GlaxoSmithKline plc. Business Overview
Table 88. GlaxoSmithKline plc. Cutaneous Horn Treatment Product
Table 89. GlaxoSmithKline plc. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline plc. Recent Development
Table 91. Vidac Pharma Company Details
Table 92. Vidac Pharma Business Overview
Table 93. Vidac Pharma Cutaneous Horn Treatment Product
Table 94. Vidac Pharma Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 95. Vidac Pharma Recent Development
Table 96. Bausch Health Companies Inc. Company Details
Table 97. Bausch Health Companies Inc. Business Overview
Table 98. Bausch Health Companies Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 99. Bausch Health Companies Inc. Recent Development
Table 100. ImClone Systems Incorporated Company Details
Table 101. ImClone Systems Incorporated Business Overview
Table 102. ImClone Systems Incorporated Cutaneous Horn Treatment Product
Table 103. ImClone Systems Incorporated Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 104. ImClone Systems Incorporated Recent Development
Table 105. Sanofi SA Company Details
Table 106. Sanofi SA Business Overview
Table 107. Sanofi SA Cutaneous Horn Treatment Product
Table 108. Sanofi SA Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 109. Sanofi SA Recent Development
Table 110. Ushio, Inc. Company Details
Table 111. Ushio, Inc. Business Overview
Table 112. Ushio, Inc. Cutaneous Horn Treatment Product
Table 113. Ushio, Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 114. Ushio, Inc. Recent Development
Table 115. Hetero Pharmaceuticals Company Details
Table 116. Hetero Pharmaceuticals Business Overview
Table 117. Hetero Pharmaceuticals Cutaneous Horn Treatment Product
Table 118. Hetero Pharmaceuticals Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 119. Hetero Pharmaceuticals Recent Development
Table 120. Merck & Co., Inc. Company Details
Table 121. Merck & Co., Inc. Business Overview
Table 122. Merck & Co., Inc. Cutaneous Horn Treatment Product
Table 123. Merck & Co., Inc. Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 124. Merck & Co., Inc. Recent Development
Table 125. Cipla Limited Company Details
Table 126. Cipla Limited Business Overview
Table 127. Cipla Limited Cutaneous Horn Treatment Product
Table 128. Cipla Limited Revenue in Cutaneous Horn Treatment Business (2016-2021) & (US$ Million)
Table 129. Cipla Limited Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Horn Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Laser Devices Features
Figure 4. Global Cutaneous Horn Treatment Market Share by Application: 2020 VS 2027
Figure 5. Retail Pharmacy Case Studies
Figure 6. Drugstore Case Studies
Figure 7. E-Commerce Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Cutaneous Horn Treatment Report Years Considered
Figure 12. Global Cutaneous Horn Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cutaneous Horn Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cutaneous Horn Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Cutaneous Horn Treatment Market Share by Regions (2022-2027)
Figure 16. Global Cutaneous Horn Treatment Market Share by Players in 2020
Figure 17. Global Top Cutaneous Horn Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Horn Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cutaneous Horn Treatment Revenue in 2020
Figure 19. Global Cutaneous Horn Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Cutaneous Horn Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cutaneous Horn Treatment Market Share by Type (2016-2027)
Figure 23. North America Cutaneous Horn Treatment Market Share by Application (2016-2027)
Figure 24. North America Cutaneous Horn Treatment Market Share by Country (2016-2027)
Figure 25. United States Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cutaneous Horn Treatment Market Share by Type (2016-2027)
Figure 29. Europe Cutaneous Horn Treatment Market Share by Application (2016-2027)
Figure 30. Europe Cutaneous Horn Treatment Market Share by Country (2016-2027)
Figure 31. Germany Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cutaneous Horn Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cutaneous Horn Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cutaneous Horn Treatment Market Share by Region (2016-2027)
Figure 41. China Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cutaneous Horn Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Cutaneous Horn Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Cutaneous Horn Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cutaneous Horn Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cutaneous Horn Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cutaneous Horn Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cutaneous Horn Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche AG Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 61. Pfizer Inc. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 63. Meda Ab Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 64. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 65. GlaxoSmithKline plc. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 66. Vidac Pharma Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 67. Bausch Health Companies Inc. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 68. ImClone Systems Incorporated Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 69. Sanofi SA Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 70. Ushio, Inc. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 71. Hetero Pharmaceuticals Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 72. Merck & Co., Inc. Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 73. Cipla Limited Revenue Growth Rate in Cutaneous Horn Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Radiation Injury Treatment Market The global Cutaneous Radiation Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…- 世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Lupus Erythematosus (CLE) Treatment Market The global Cutaneous Lupus Erythematosus (CLE) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
- 世界の皮膚肥満細胞症治療市場規模・現状・予測（2021年-2027年） Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis. Market Analysis and Insights: Gl…
- 世界の皮膚T細胞リンパ腫（CTCL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous T-Cell Lymphoma (CTCL) Treatment Market The global Cutaneous T-Cell Lymphoma (CTCL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…